Editorial: Peptidyl-Prolyl Isomerases in Human Pathologies

Front Pharmacol. 2019 Jul 11:10:794. doi: 10.3389/fphar.2019.00794. eCollection 2019.

Authors

Tiziano Tuccinardi¹, Flavio Rizzolio^{2

3}

Affiliations

¹ Department of Pharmacy, University of Pisa, Pisa, Italy.
² Department of Translational Research, Pathology Unit, National Cancer Institute-CRO-IRCSS, Aviano, Italy.
³ Department of Molecular Sciences and Nanosystems, Ca' Foscari University of Venezia, Venice, Italy.

No abstract available

Keywords: cancer; human pathologies; peptidyl-prolyl isomerases; signal transduction; therapy.

Publication types

Editorial